It has shown promising results in animal trials, and the next step is to refine it and test its safety and effectiveness in humans. This is an exciting step towards a potential curative treatment for heart disease, which could improve the quality of life of millions of people around the world.
This research involved the Department of Pharmacology, Gurdon Institute, QIMR Berghofer Medical Research Institute and AstraZeneca.
Learn more here »